Simplex Trading’s Achieve Life Sciences ACHV Stock Holding History

Simplex Trading’s Portfolio ACHV Stock Details ACHV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$105K	Buy	16,100 +9,200	+133%	+$43.9K	﹤0.01%	5482
2026 Q1	$20.3K	Buy	6,900 +6,100	+763%	+$27.1K	﹤0.01%	6771
2025 Q4	$3.98K	Sell	800 -6,500	-89%	-$28.3K	﹤0.01%	7547
2025 Q3	$22K	Buy	7,300 +5,400	+284%	+$14.8K	﹤0.01%	7234
2025 Q2	$4K	Buy	+1,900	New	+$5.41K	﹤0.01%	7801
2023 Q4	–	Sell	-3,900	Closed	-$16K	–	8656
2023 Q3	$16K	Sell	3,900 -19,900	-84%	-$100K	﹤0.01%	6793
2023 Q2	$123K	Buy	23,800 +17,400	+272%	+$122K	﹤0.01%	4833
2023 Q1	$43K	Buy	+6,400	New	+$30.4K	﹤0.01%	6087
2022 Q3	–	Sell	-500	Closed	-$2K	–	9781
2022 Q2	$2K	Sell	500 -300	-38%	-$2.04K	﹤0.01%	9281
2022 Q1	$6K	Sell	800 -2,000	-71%	-$14.9K	﹤0.01%	9252
2021 Q4	$21K	Buy	+2,800	New	+$22K	﹤0.01%	8289
2016 Q2	–	Hold	0	–	-$25K	–	5720
2016 Q1	–	Hold	0	–	–	–	2582
2015 Q4	–	Hold	0	–	–	–	2466

Other funds holding ACHV

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PBM

Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Simplex Trading's ACHV Position: Q1 2026 in Review

Simplex Trading sold out of Achieve Life Sciences (ACHV) in Q1 2026, closing a stake of 17,338 shares — an estimated $77K sold.

Simplex Trading first reported a position in ACHV in Q4 2015 and held it in 13 quarters. The position peaked at $94K in Q1 2022. 81 funds tracked by Wall St. Rank hold ACHV as of Q1 2026.

Simplex Trading reported no remaining Achieve Life Sciences position as of Q1 2026 after selling out during the quarter.
Simplex Trading sold 17,338 Achieve Life Sciences shares in Q1 2026, an estimated $77K.
Simplex Trading first reported a position in Achieve Life Sciences in Q4 2015 and held it in 13 quarters.
Simplex Trading's Achieve Life Sciences position peaked at $94K in Q1 2022.
81 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.